GB0300881D0 - Therapeutic treatment - Google Patents

Therapeutic treatment

Info

Publication number
GB0300881D0
GB0300881D0 GBGB0300881.0A GB0300881A GB0300881D0 GB 0300881 D0 GB0300881 D0 GB 0300881D0 GB 0300881 A GB0300881 A GB 0300881A GB 0300881 D0 GB0300881 D0 GB 0300881D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic treatment
therapeutic
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0300881.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UK Secretary of State for Defence
Original Assignee
UK Secretary of State for Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UK Secretary of State for Defence filed Critical UK Secretary of State for Defence
Priority to GBGB0300881.0A priority Critical patent/GB0300881D0/en
Publication of GB0300881D0 publication Critical patent/GB0300881D0/en
Priority to PCT/GB2004/000114 priority patent/WO2004062559A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4615—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4648—Bacterial antigens
    • A61K39/464819—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB0300881.0A 2003-01-15 2003-01-15 Therapeutic treatment Ceased GB0300881D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0300881.0A GB0300881D0 (en) 2003-01-15 2003-01-15 Therapeutic treatment
PCT/GB2004/000114 WO2004062559A2 (en) 2003-01-15 2004-01-14 Use of microcapsules comprising an antigen for the manufacture of an ex-vivo medicament to initiate an immune response

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0300881.0A GB0300881D0 (en) 2003-01-15 2003-01-15 Therapeutic treatment

Publications (1)

Publication Number Publication Date
GB0300881D0 true GB0300881D0 (en) 2003-02-12

Family

ID=9951177

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0300881.0A Ceased GB0300881D0 (en) 2003-01-15 2003-01-15 Therapeutic treatment

Country Status (2)

Country Link
GB (1) GB0300881D0 (en)
WO (1) WO2004062559A2 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL84167A (en) * 1986-10-24 1991-04-15 Southern Res Inst Oral delivery of bioactive agents to and through the peyer's patch by use of microencapsulation
US6013258A (en) * 1997-10-09 2000-01-11 Zycos Inc. Immunogenic peptides from the HPV E7 protein
AU4139801A (en) * 1999-12-06 2001-06-12 Board Of Trustees Of The University Of Arkansas, The Controlled delivery of antigens
DE60121925T2 (en) * 2000-03-22 2007-03-01 The Secretary Of State For Defence, Salisbury MEDICINAL PRODUCT FOR ADMINISTRATION ON MICE
US6565888B1 (en) * 2000-08-23 2003-05-20 Alkermes Controlled Therapeutics, Inc. Methods and compositions for the targeted delivery of biologically active agents
CN101428006A (en) * 2000-09-28 2009-05-13 诺华疫苗和诊断公司 Microparticle compositions and methods for the manufacture thereof
WO2002080648A2 (en) * 2001-04-05 2002-10-17 Chiron Corporation Mucosal boosting following parenteral priming

Also Published As

Publication number Publication date
WO2004062559A3 (en) 2004-09-02
WO2004062559A2 (en) 2004-07-29

Similar Documents

Publication Publication Date Title
GB0316912D0 (en) Therapeutic treatment
GB0201850D0 (en) Therapeutic treatment
GB0216321D0 (en) Therapeutic treatment
GB0320806D0 (en) Therapeutic treatment
HK1078784A1 (en) Therapeutic treatment
GB0223367D0 (en) Therapeutic treatment
GB0329275D0 (en) Therapeutic treatment
GB0210464D0 (en) Therapeutic treatment
GB0307863D0 (en) Therapeutic treatment
GB0300428D0 (en) Medical treatment
GB0313772D0 (en) Therapeutic treatment
GB0327493D0 (en) Treatment medicament
GB0306165D0 (en) Medical treatment
GB0300881D0 (en) Therapeutic treatment
GB0321649D0 (en) Therapeutic treatment
GB0321236D0 (en) Therapeutic treatment
GB0321235D0 (en) Therapeutic treatment
GB0321234D0 (en) Therapeutic treatment
GB0321650D0 (en) Therapeutic treatment
GB0322000D0 (en) Therapeutic treatment
GB0321233D0 (en) Therapeutic treatment
GB0318552D0 (en) Therapeutic treatment
GB0318323D0 (en) Therapeutic treatment
SI1553950T1 (en) Therapeutic treatment
GB0207138D0 (en) Novel therapeutic treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)